Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of East Anglia Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Bournemouth University Featured PhD Programmes
Coventry University Featured PhD Programmes
University of Nottingham Featured PhD Programmes

MRes: Novel kinase inhibitors as anti tumour agents

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr DUncan Gill
  • Application Deadline
    No more applications being accepted
  • Funded PhD Project (Students Worldwide)
    Funded PhD Project (Students Worldwide)

About This PhD Project

Project Description

The project will develop novel inhibitors of mTOR kinase and other related cancer chemotherapy targets, extending our recent published work on bridged bicyclic morpholines (Chemical Communications 2013, 49, 8931). Biological evaluation of these compounds using a combination of cell-free and cell-based assays will be employed to determine the extent of mTOR pathway modulation in normal and cancer cells. The work will be focused on synthetic organic chemistry. The successful candidate will have a degree in chemistry or pharmacy, excellent practical skills and a strong interest in synthetic and medicinal chemistry.

This project is only for one year.


FindAPhD. Copyright 2005-2018
All rights reserved.